Fig. 5From: Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysisIncidence probability estimates obtained with the naïve KM estimator, the weighted KM estimator stratifying only for 1 covariate (risk group) or for 2 covariates (risk group and age at diagnosis) and the weighted Cox model including only risk group or both risk group and age at diagnosis as covariatesBack to article page